As between the Parties, Teijin has the sole right (but not the obligation) to defend and enforce Sole Patent Rights, the Teijin Patent Rights and the Teijin Know-How.[*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.
Subject to the terms and conditions of this Agreement, Teijin hereby grants to Radius during the Term an exclusive (even as to Teijin), royalty-free license or sublicense, as applicable, under the Teijin Know-How and Teijin Patent Rights, to Develop, Manufacture and Commercialize Abalo-SC in the Field, in all countries of the world other than Japan.
Nothing in this ARTICLE X shall require Teijin to consent to any settlement that is reasonably anticipated by Teijin to have a materially adverse impact upon any Teijin Patent in the Territory, or to Develop, use, sell, offer for sale, have sold, import, and otherwise Commercialize the Licensed Product or Drug Product or Finished Product hereunder in the Territory or to Manufacture anywhere in the world for such Development, use, sale, or import anywhere in the Territory.
Teijin has the sole right (but not the obligation) to file, prosecute, and maintain its Sole Patent Rights and the Teijin Patent Rights.